Download PDF
1 / Pages

Other users also viewed these articles

Prevalence rates of overweight and obesity and their associations with cardiometabolic and renal factors. SIMETAP-OB study Antonio Ruiz-García; Ezequiel Arranz-Martínez; Luis Enrique Morales-Cobos; Juan Carlos García-Álvarez; Nerea Iturmendi-Martínez; Montserrat Rivera-Teijido;
Clin Investig Arterioscler. 2022;34:291-302
Multizonal observational study conducted by clinical practitioners on Repatha® use in patients with hyperlipidemia (ZERBINI): Colombian results Heidy M. Roncancio; Julián R. Lugo-Peña; Ángel A. García; Janeth Leal; Carlos A. Hoyos; Johnny A. Beltrán; César L. Cruz; Carol Paez-Cano; Mariana Pineda-Posada; Eduardo Contreras;
Clin Investig Arterioscler. 2024;36:22-32
Analysis of the evolocumab (Repatha®) patient support program for patients with cardiovascular disease in Colombia Ángel Alberto García-Peña; Mariana Pineda-Posada; Carol Páez-Canro; César Cruz; Daniel Samacá-Samacá;
Clin Investig Arterioscler. 2023;35:280-9